| Not Yet Recruiting | Single-channel Fibroid Morcellation System Used in Clinical Research on Laparoscopic Myomectomy NCT07512973 | First People's Hospital of Hangzhou | N/A |
| Not Yet Recruiting | Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief NCT07501676 | Weill Medical College of Cornell University | N/A |
| Recruiting | to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia NCT07378098 | JW Pharmaceutical | Phase 3 |
| Not Yet Recruiting | Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model NCT07177534 | Tongji Hospital | — |
| Recruiting | An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Sympt NCT07078682 | Zenchi, Inc. | N/A |
| Completed | Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies NCT07046949 | Yuri Semenyuk Rivne Regional Clinical Hospital | N/A |
| Active Not Recruiting | Use of Nitrous Oxide During Office Hysteroscopy NCT07074795 | Maaynei Hayesha Medical Center | N/A |
| Completed | A Trial of SHR7280 in Healthy Subjects NCT06969664 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, NCT06949124 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Not Yet Recruiting | A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gy NCT06828419 | Second Affiliated Hospital of Wenzhou Medical University | N/A |
| Active Not Recruiting | Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of C NCT07486622 | Chang Zhou | — |
| Completed | Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy NCT06768086 | Centro di Ricerca Clinica Salentino | — |
| Recruiting | Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids NCT06671548 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbea NCT06055114 | Lin Yuan | — |
| Recruiting | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women NCT05862272 | Sumitomo Pharma Switzerland GmbH | Phase 3 |
| Unknown | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. NCT05620355 | Bio Genuine (Shanghai) Biotech Co., Ltd. | Phase 3 |
| Recruiting | Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid NCT05448365 | Lo.Li.Pharma s.r.l | N/A |
| Active Not Recruiting | Effect of Addition of Steroids on Duration of Analgesia NCT04126824 | University of California, Los Angeles | EARLY_Phase 1 |
| Terminated | A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participa NCT05026502 | AbbVie | — |
| Unknown | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fi NCT05078307 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Pharmacokinetics and Hepatic Safety of EGCG NCT04177693 | Yale University | Phase 1 |
| Withdrawn | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patie NCT04567095 | Allergan | — |
| Withdrawn | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healt NCT04567589 | Allergan | — |
| Active Not Recruiting | Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myom NCT03948789 | Krankenhaus Nordwest | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associa NCT03886220 | AbbVie | Phase 4 |
| Withdrawn | Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids NCT03699176 | Bayer | Phase 3 |
| Completed | Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated NCT03751124 | Myovant Sciences GmbH | Phase 3 |
| Unknown | Association Between Vitamin D and the Risk of Uterine Fibroids NCT03586947 | Second Affiliated Hospital of Wenzhou Medical University | N/A |
| Completed | Pharmacokinetics and Safety of Vilaprisan in Renal Impairment NCT03411980 | Bayer | Phase 1 |
| Terminated | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) NCT03400956 | Bayer | Phase 3 |
| Terminated | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) NCT03400943 | Bayer | Phase 3 |
| Unknown | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatos NCT03500367 | Peking Union Medical College Hospital | Phase 4 |
| Completed | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids NCT03317795 | Shannon K. Laughlin-Tommaso | Phase 4 |
| Completed | Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of H NCT03271489 | AbbVie | Phase 3 |
| Terminated | A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids NCT03240523 | Bayer | Phase 3 |
| Completed | Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids NCT02844920 | Gynesonics | — |
| Terminated | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids NCT03194646 | Bayer | Phase 3 |
| Completed | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids NCT03070951 | ObsEva SA | Phase 3 |
| Completed | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids NCT03070899 | ObsEva SA | Phase 3 |
| Completed | Tailored Radiofrequency Ablation of Uterine Myomas NCT04091529 | International Evangelical Hospital | N/A |
| Unknown | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment NCT02942537 | Karolinska Institutet | Phase 2 / Phase 3 |
| Unknown | Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization NCT02884960 | Gary Siskin, MD | N/A |
| Completed | An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual NCT02925494 | AbbVie | Phase 3 |
| Terminated | An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopa NCT02811159 | Repros Therapeutics Inc. | Phase 2 |
| Completed | Point of Care 3D Ultrasound for Various Applications: A Pilot Study NCT02831556 | Duke University | — |
| Unknown | Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women NCT02440750 | University of Cagliari | Phase 4 |
| Completed | A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated NCT02655224 | Takeda | Phase 3 |
| Completed | A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in NCT02655237 | Takeda | Phase 3 |
| Completed | Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heav NCT02691494 | AbbVie | Phase 3 |
| Unknown | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) NCT02914704 | Turku University Hospital | N/A |
| Completed | Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heav NCT02654054 | AbbVie | Phase 3 |
| Completed | Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Ter NCT02748460 | PregLem SA | — |
| Completed | PerClot Compared to Usual Care in Gynaecology Procedures NCT02835391 | CryoLife Europa | N/A |
| Terminated | Ulipristal Acetate 10 mg and Asisted Reproduction NCT02425878 | Instituto Valenciano de Infertilidad, IVI VALENCIA | Phase 3 |
| Completed | Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy NCT02472184 | University of South Florida | N/A |
| Completed | Pilot of Letrozole for Uterine Myomas NCT02470741 | University of California, San Francisco | Phase 4 |
| Completed | A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 1 NCT02301897 | Repros Therapeutics Inc. | Phase 2 |
| Completed | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fi NCT02323646 | Repros Therapeutics Inc. | Phase 2 |
| Unknown | Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy NCT04400942 | Ospedale Policlinico San Martino | — |
| Completed | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids NCT02819609 | Quintiles, Inc. | — |
| Unknown | Clinical Test of the MRgHIFU System on Uterine Fibroids NCT02283502 | Chin-Jung Wang | Phase 1 |
| Active Not Recruiting | Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry NCT02100904 | University of California, San Francisco | — |
| Completed | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques NCT02086370 | University Magna Graecia | N/A |
| Completed | AMH Levels Change During Treatment With GnRh Agonist NCT02086279 | University Magna Graecia | N/A |
| Unknown | Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy NCT02086344 | University Magna Graecia | N/A |
| Completed | Vaginal vs. Laparoscopic Hysterectomy NCT02059954 | Medical University of Graz | N/A |
| Completed | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives NCT01852734 | Odense University Hospital | N/A |
| Completed | Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? NCT02192606 | Brigham and Women's Hospital | N/A |
| Completed | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography NCT01992718 | University of Michigan | EARLY_Phase 1 |
| Withdrawn | a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. NCT01971060 | The Advanced Gynecologic Surgery Institute | N/A |
| Completed | Uterine Leiomyoma Treatment With Radiofrequency Ablation NCT01840124 | University of California, San Francisco | N/A |
| Completed | Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroid NCT01817530 | AbbVie | Phase 2 |
| Terminated | Post Market Evaluation of Acessa With TAG NCT01842789 | Acessa Health, Inc. | N/A |
| Terminated | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intraute NCT01998854 | Gynesonics | — |
| Completed | Post Market TRUST Study NCT01563783 | Acessa Health, Inc. | N/A |
| Completed | Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions NCT01750008 | Acessa Health, Inc. | N/A |
| Completed | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatm NCT01739621 | Repros Therapeutics Inc. | Phase 2 |
| Completed | Extension of Study ZPV-200 NCT01631903 | Repros Therapeutics Inc. | Phase 2 |
| Terminated | Embozene Microspheres for Uterine Fibroid Embolization (UFE) NCT01675011 | Boston Scientific Corporation | N/A |
| Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata NCT01642472 | PregLem SA | Phase 3 |
| Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata NCT01629563 | PregLem SA | Phase 3 |
| Terminated | Fibroid Ablation Study - Large Fibroids NCT01539187 | Gynesonics | N/A |
| Unknown | A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-ope NCT01635452 | PregLem SA | — |
| Terminated | Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids NCT01504308 | Philips Healthcare | Phase 2 / Phase 3 |
| Completed | ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids NCT01285960 | InSightec | N/A |
| Completed | China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids NCT01588899 | Philips Healthcare | N/A |
| Completed | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine NCT01451424 | Repros Therapeutics Inc. | Phase 2 |
| Terminated | Preemptive Analgesia Following Uterine Artery Embolization NCT01555073 | Northwestern University | Phase 4 |
| Completed | Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids NCT01452659 | Takeda | Phase 2 |
| Completed | Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids NCT01441635 | AbbVie (prior sponsor, Abbott) | Phase 2 |
| Withdrawn | Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine NCT01328067 | InSightec | N/A |
| Completed | Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids NCT01377519 | University of California, San Francisco | N/A |
| Terminated | Fibroid Ablation Study NCT01226290 | Gynesonics | N/A |
| Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) NCT01252069 | PregLem SA | Phase 3 |
| Completed | MyoSure Hysteroscopic Tissue Removal System Registry Study NCT01369758 | Hologic, Inc. | N/A |
| Completed | Magnetic Resonance Elastography (MRE) of Uterine Fibroids NCT01229826 | Mayo Clinic | — |
| Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata NCT01156857 | PregLem SA | Phase 3 |
| Completed | HOME Study: Hysteroscopic Office Myomectomy Evaluation NCT01152112 | Hologic, Inc. | N/A |
| Completed | Safety Study of ExAblate for the Treatment of Uterine Fibroids NCT01142791 | InSightec | N/A |
| Completed | The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine NCT00995878 | Mayo Clinic | Phase 4 |
| Terminated | A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D- NCT01140555 | Ethicon, Inc. | N/A |
| Terminated | Mifepristone to Treat Uterine Fibroids NCT01786226 | Mediterranea Medica S. L. | Phase 2 / Phase 3 |
| Completed | A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine NCT01092988 | InSightec | N/A |
| Completed | Minimally Invasive Benign Hysterectomy NCT01865929 | Region Skane | N/A |
| Completed | Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System NCT00979342 | Hologic, Inc. | N/A |
| Completed | Biologic Predictors of Leiomyoma Treatment Outcomes NCT01936493 | Elizabeth A. Stewart | — |
| Terminated | Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibro NCT01834703 | Chinese University of Hong Kong | N/A |
| Completed | Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uteri NCT00897897 | Philips Healthcare | N/A |
| Terminated | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids NCT01069120 | Repros Therapeutics Inc. | Phase 3 |
| Completed | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids NCT00874029 | Acessa Health, Inc. | N/A |
| Terminated | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids NCT00853567 | Repros Therapeutics Inc. | Phase 3 |
| Completed | Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids NCT00837161 | Philips Healthcare | Phase 1 / Phase 2 |
| Unknown | The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids NCT00860002 | Taipei Veterans General Hospital, Taiwan | — |
| Terminated | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids NCT00785356 | Repros Therapeutics Inc. | Phase 3 |
| Terminated | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids NCT00737282 | Repros Therapeutics Inc. | Phase 3 |
| Withdrawn | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ab NCT00768742 | Gynesonics | N/A |
| Terminated | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fib NCT00735553 | Repros Therapeutics Inc. | Phase 3 |
| Completed | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata NCT00731341 | Boston Scientific Corporation | N/A |
| Terminated | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 NCT00958893 | Repros Therapeutics Inc. | Phase 2 |
| Terminated | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids NCT00702702 | Repros Therapeutics Inc. | Phase 3 |
| Completed | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids NCT00886873 | Mediterranea Medica S. L. | Phase 2 / Phase 3 |
| Terminated | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibro NCT00683917 | Repros Therapeutics Inc. | Phase 2 |
| Terminated | Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding NCT00496080 | Ethicon, Inc. | N/A |
| Terminated | Uterine Artery Occlusion for Fibroid Related Bleeding NCT00496067 | Ethicon, Inc. | N/A |
| Completed | Mifepristone for Treatment of Uterine Fibroids NCT00712595 | Mediterranea Medica S. L. | Phase 2 / Phase 3 |
| Completed | MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication NCT00365989 | InSightec | Phase 3 |
| Completed | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 NCT00958334 | Repros Therapeutics Inc. | Phase 2 |
| Completed | A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. NCT00776074 | Takeda | Phase 2 |
| Completed | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery NCT01388907 | Medtronic - MITG | Phase 4 |
| Completed | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids NCT00882258 | Repros Therapeutics Inc. | Phase 2 |
| Completed | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation NCT00295217 | InSightec | Phase 3 |
| Completed | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Ut NCT00628901 | Boston Scientific Corporation | Phase 4 |
| Terminated | Uterine Fibroid Pregnancy Registry NCT00232713 | Syneos Health | — |
| Completed | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids NCT00166270 | InSightec | N/A |
| Unknown | Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata NCT00163930 | Bayside Health | — |
| Completed | Study of Asoprisnil in the Treatment of Uterine Fibroids. NCT00156156 | Abbott | Phase 3 |
| Completed | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue NCT00579475 | Karolinska Institutet | Phase 1 |
| Completed | Safety of Treatment of Uterine Fibroids With Asoprisnil NCT00156208 | Abbott | Phase 3 |
| Withdrawn | Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids NCT00180739 | Imperial College London | Phase 4 |
| Terminated | Radiofrequency Ablation of Uterine Fibroids NCT00584207 | University of California, Davis | EARLY_Phase 1 |
| Completed | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids NCT00152256 | Abbott | Phase 3 |
| Completed | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hys NCT00150644 | Abbott | Phase 2 |
| Completed | Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids NCT00159328 | Imperial College London | Phase 4 |
| Completed | Women's Use of Alternative Medicine: A Multiethnic Study NCT00067249 | National Center for Complementary and Integrative Health (NCCIH) | — |
| Unknown | Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fi NCT00277680 | Ullevaal University Hospital | N/A |
| Completed | Risk Factors for Uterine Fibroids: A Case Control Study NCT00339547 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Withdrawn | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms NCT00874302 | Repros Therapeutics Inc. | Phase 3 |
| Completed | Uterine Artery Embolization for Symptomatic Fibroids NCT00354471 | University of Manitoba | — |